Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects

The trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT03679143).